| Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 | 10/09 16:05 | globenewswire.com |
| Adaptive Announces IVDR Certification for clonoSEQ® in European Union | 08/29 07:30 | globenewswire.com |
| Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference | 08/22 16:03 | globenewswire.com |
| Adaptive Biotechnologies Corporation (ADPT) Q2 2024 Earnings Call Transcript | 08/01 22:25 | seekingalpha.com |
| Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates | 08/01 20:00 | zacks.com |
| Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates | 08/01 19:20 | zacks.com |
| Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results | 08/01 16:05 | globenewswire.com |
| 3 Precision Medicine Stocks Tailoring Treatments | 07/21 06:00 | investorplace.com |
| Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 | 07/11 16:05 | globenewswire.com |
| Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress | 05/31 07:30 | globenewswire.com |